Skip to main content
Cidara Therapeutics, Inc. logo

Cidara Therapeutics, Inc. — Investor Relations & Filings

Ticker · CDTX ISIN · US1717572069 LEI · 549300IHQ9Z7RI1X2D22 US Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2015-11-16 Earnings Release
Country US United States of America
Listing US CDTX

About Cidara Therapeutics, Inc.

https://www.cidara.com/

Cidara Therapeutics, Inc. is a biotechnology company that develops targeted immunotherapies and novel anti-infectives for patients with serious diseases. The company utilizes its proprietary Cloudbreak® platform to create drug-Fc conjugates (DFCs). These DFCs are engineered as 'single molecule cocktails' by coupling targeted small molecules or peptides to a human antibody fragment (Fc). This approach is designed to directly inhibit disease targets, such as fungal or viral pathogens, while simultaneously engaging the patient's immune system. The company's focus is on developing therapies for the treatment and prevention of life-threatening infections and other serious conditions.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release reporting financial results for the third quarter ended September 30, 2015. The document itself is short (3170 characters) and primarily serves to furnish the press release as an exhibit. There are no detailed financial statements or substantive financial data within the document itself, only a summary and reference to the press release. According to the rules, such a document is an initial announcement of quarterly financial results, which fits the definition of an Earnings Release (ER).
2015-11-16 English
Major Shareholding Notification 2015
Major Shareholding Notification
2015-09-10 English
10-Q
Interim / Quarterly Report Q2 2015
2015-08-11 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing dated August 11, 2015, reporting the issuance of a press release with financial results for the second quarter ended June 30, 2015. The text explicitly states that the financial results are reported in a press release attached as Exhibit 99.1. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The length of the document is only 2590 characters, which is short and consistent with an announcement rather than a full financial report. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements and miscellaneous filings that do not fit other categories.
2015-08-11 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 4, 2015. It reports the entry into a material definitive agreement, specifically a lease amendment expanding leased space and extending the lease term. The document is short (2782 characters) and contains a specific event announcement rather than comprehensive financial data or detailed reports. It does not contain financial statements or detailed management discussion. Therefore, it is a regulatory announcement of a material event, fitting the category of Regulatory Filings (RNS) rather than a full financial report or other specific filing types.
2015-08-07 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 9, 2015. The content focuses on Item 5.02, which relates to the departure, election, or appointment of directors or certain officers, specifically detailing compensatory arrangements (salary increases) for named executive officers. There is no financial report, earnings data, or other report type content. The document is an announcement of management changes and compensation adjustments. According to the filing definitions, this fits best under 'Board/Management Information (MANG)' which covers announcements of changes in the company's board of directors or senior management. The document length is 2548 characters, which is short and consistent with an announcement rather than a full report. Therefore, the classification is MANG with high confidence.
2015-06-12 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.